Cipla Quality Chemical Industries Limited (CiplaQCIL) is a state-of-the-art pharmaceutical manufacturing company located in Kampala, Uganda. The company manufactures Anti-retroviral (ARVs), Artemisinin-based Combination Therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, Malaria and Hepatitis.

Latest Updates

September 25, 2019

RECALL OF HEPATITIS B DRUG BY CIPLA QUALITY CHEMICAL INDUSTRIES LTD

PRESS STATEMENT: RECALL OF HEPATITIS B DRUG BY CIPLA QUALITY CHEMICAL INDUSTRIES LTD Referenceis made to several media reports that have been circulating in regard to […]
September 19, 2018

Cipla Quality Chemical Industries Limited Bell Ringing and First Day of Trading on the Uganda Securities Exchange

Kampala. Cipla Quality Chemical Industries Limited (CiplaQCIL), a leading pharmaceutical manufacturing company in Sub Saharan Africa operating in Uganda, today officially listed on the Uganda Securities […]
September 19, 2018

Cipla Quality Chemical Industries Ltd: Changes to Executive Management

In accordance with its continuing listing obligations, Cipla Quality Chemical Industries Ltd (“CiplaQCIL”) hereby informs its shareholders and general public of the following changes in its […]